Cerecor Inc (CERC) Director Armistice Capital, Llc Buys 17,145 Shares

Cerecor Inc (NASDAQ:CERC) Director Armistice Capital, Llc purchased 17,145 shares of the stock in a transaction dated Friday, July 27th. The shares were acquired at an average price of $4.43 per share, with a total value of $75,952.35. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Armistice Capital, Llc also recently made the following trade(s):

  • On Monday, July 30th, Armistice Capital, Llc purchased 2,200 shares of Cerecor stock. The shares were acquired at an average price of $4.26 per share, with a total value of $9,372.00.
  • On Wednesday, July 25th, Armistice Capital, Llc bought 7,700 shares of Cerecor stock. The shares were purchased at an average price of $4.34 per share, with a total value of $33,418.00.
  • On Wednesday, July 18th, Armistice Capital, Llc bought 2,500 shares of Cerecor stock. The shares were purchased at an average price of $4.35 per share, with a total value of $10,875.00.
  • On Monday, July 16th, Armistice Capital, Llc bought 17,800 shares of Cerecor stock. The shares were purchased at an average price of $4.26 per share, with a total value of $75,828.00.
  • On Thursday, June 28th, Armistice Capital, Llc bought 14,400 shares of Cerecor stock. The shares were purchased at an average price of $4.06 per share, with a total value of $58,464.00.
  • On Wednesday, May 23rd, Armistice Capital, Llc bought 300 shares of Cerecor stock. The shares were purchased at an average price of $3.85 per share, with a total value of $1,155.00.
  • On Monday, May 21st, Armistice Capital, Llc bought 42,159 shares of Cerecor stock. The shares were purchased at an average price of $3.77 per share, with a total value of $158,939.43.
  • On Tuesday, May 15th, Armistice Capital, Llc bought 92,700 shares of Cerecor stock. The shares were purchased at an average price of $3.51 per share, with a total value of $325,377.00.

Shares of Cerecor stock opened at $4.46 on Friday. Cerecor Inc has a 12 month low of $0.52 and a 12 month high of $5.74. The stock has a market cap of $133.06 million, a P/E ratio of 17.67 and a beta of 1.28. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.91 and a quick ratio of 0.67.

Cerecor (NASDAQ:CERC) last posted its quarterly earnings results on Friday, May 11th. The company reported ($0.07) earnings per share (EPS) for the quarter. The company had revenue of $4.48 million during the quarter. Cerecor had a net margin of 15.71% and a return on equity of 41.38%. equities analysts expect that Cerecor Inc will post -0.39 EPS for the current fiscal year.

Separately, TheStreet cut Cerecor from a “c-” rating to a “d” rating in a report on Friday, June 22nd.

A number of hedge funds have recently bought and sold shares of CERC. O Shaughnessy Asset Management LLC acquired a new stake in Cerecor in the 1st quarter valued at about $315,000. Northern Trust Corp raised its position in Cerecor by 182.0% in the 1st quarter. Northern Trust Corp now owns 31,506 shares of the company’s stock valued at $135,000 after purchasing an additional 20,333 shares in the last quarter. Spark Investment Management LLC acquired a new stake in Cerecor in the 2nd quarter valued at about $288,000. Finally, BlackRock Inc. raised its position in Cerecor by 630.4% in the 2nd quarter. BlackRock Inc. now owns 27,520 shares of the company’s stock valued at $120,000 after purchasing an additional 23,752 shares in the last quarter. 53.43% of the stock is currently owned by institutional investors.

Cerecor Company Profile

Cerecor Inc, a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Veripred, and Ulesfia for the treatment of inflammation of the skin, joints, lungs, and other organs, as well as asthma, allergies, arthritis, and head lice infestation.

Read More: What kind of dividend yield to CEF’s pay?

Insider Buying and Selling by Quarter for Cerecor (NASDAQ:CERC)

Receive News & Ratings for Cerecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply